Oncolytic virus

Results: 117



#Item
1Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664

Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664

Add to Reading List

Source URL: www.takara-bio.co.jp

Language: English - Date: 2017-06-02 05:25:57
    2Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano

    Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano

    Add to Reading List

    Source URL: www.takara-bio.co.jp

    Language: English - Date: 2016-10-24 01:27:48
      3When Patients Win, We All Win™ Provectus Biopharmaceuticals, Inc Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigation

      When Patients Win, We All Win™ Provectus Biopharmaceuticals, Inc Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigation

      Add to Reading List

      Source URL: www.pvct.com

      Language: English - Date: 2016-08-18 16:04:23
      4Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48

      Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48" × 60".

      Add to Reading List

      Source URL: moffitt.org

      Language: English - Date: 2016-03-02 10:23:54
      5OVC Crestword copy black read

      OVC Crestword copy black read

      Add to Reading List

      Source URL: www.smilingblueskies.com

      Language: English - Date: 2016-01-22 12:27:43
      6FOR  IMMEDIATE  RELEASE        

      FOR  IMMEDIATE  RELEASE        

      Add to Reading List

      Source URL: www.versantventures.com

      Language: English - Date: 2016-01-27 13:02:32
      7WORLD PRECLINICAL CONGRESS June 14-17, 2016  Westin Boston Waterfront, Boston, MA

      WORLD PRECLINICAL CONGRESS June 14-17, 2016  Westin Boston Waterfront, Boston, MA

      Add to Reading List

      Source URL: www.worldpreclinicalcongress.com

      Language: English - Date: 2016-04-07 10:46:41
      8F E AT U R E Gene therapy finds its niche Cormac Sheridan Gene therapy is finally poised to make a contribution to the treatment of debilitating, highly penetrant genetic diseases that have proved intractable to other r

      F E AT U R E Gene therapy finds its niche Cormac Sheridan Gene therapy is finally poised to make a contribution to the treatment of debilitating, highly penetrant genetic diseases that have proved intractable to other r

      Add to Reading List

      Source URL: www.wissenschaftsdialog.de

      Language: English - Date: 2012-03-01 05:18:48
      9Late Breaking Abstracts Addendum Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah

      Late Breaking Abstracts Addendum Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah

      Add to Reading List

      Source URL: www.asgct.org

      Language: English - Date: 2013-05-10 11:29:09
      10Microsoft Word - ITOC1_Final_programme

      Microsoft Word - ITOC1_Final_programme

      Add to Reading List

      Source URL: itoc-conference.eu

      Language: English - Date: 2014-09-09 08:02:55